Parkside Financial Bank & Trust’s Biohaven BHVN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-110	Closed	-$1.24K	–	2696
2025 Q4	$1.24K	Buy	110 +34	+45%	+$421	﹤0.01%	2261
2025 Q3	$1.14K	Buy	76 +40	+111%	+$582	﹤0.01%	2229
2025 Q2	$508	Sell	36 -9	-20%	-$160	﹤0.01%	2545
2025 Q1	$1.08K	Buy	+45	New	+$1.59K	﹤0.01%	2077

Other funds holding BHVN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's BHVN Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 110 shares — an estimated $1.24K sold.

Parkside Financial Bank & Trust first reported a position in BHVN in Q1 2025 and held it in 4 quarters. The position peaked at $1.24K in Q4 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Parkside Financial Bank & Trust reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 110 Biohaven shares in Q1 2026, an estimated $1.24K.
Parkside Financial Bank & Trust first reported a position in Biohaven in Q1 2025 and held it in 4 quarters.
Parkside Financial Bank & Trust's Biohaven position peaked at $1.24K in Q4 2025.
276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.